Join
Live feed
·
INSIDERFilingvia Quantisnow
Phio Pharmaceuticals Corp. logo

SEC Form 4: Freeman Jonathan E was granted 10,000 shares, increasing direct ownership by 96% to 20,364 units

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PHIO (Phio Pharmaceuticals Corp.) and more on Quantisnow.